RCPD letters are non-publicly available and are currently located in a password protected area. If you are authorized to access RCPD letters, please sign-in through the RCPD Letters web site.
| Action Due Date |
Letter Number |
Keywords |
| 02-NOV-20 |
STC-20-059
|
Notification of the Intent to Review and Update the Generic Environmental Impact Statement for License Renewal of Nuclear Plants (NUREG-1437) (STC-20-059). STC-20-059 informs States and Indian Tribes that NRC intends to review and update NUREG-1437, "Generic Environmental Impact Statement for License Renewal of Nuclear Plants - Final Report" (LR GEIS) with scoping webinars in August 2020 and comments due by 11/2/2020. |
| 14-OCT-20 |
RCPD-20-007 |
Requesting Review of Proposed Revision to Document, "Consolidated Decommissioning Guidance: Decommissioning Process For Materials Licensees" (NUREG-1757, Volume 1, Revision 3) (RCPD-20-007). RCPD-20-007 provides Agreement States the opportunity to comment on the proposed Revision 3 of NUREG 1757, Volume 1, by 10/14/2020, 75 days after 7/31/2020. |
| 08-OCT-20 |
STC-20-060
|
Notice of Annual Organization of Agreement States and Conference of Radiation Control Program Directors Commission Briefing (STC-20-060). STC-20-060 provides notice of the Annual Organization of Agreement States (OAS) and Conference of Radiation Control Program Directors (CRCPD) Commission briefing to be held remotely on October 8, 2020, from 10:00 a.m. to 12:00 p.m. EST. |
| 25-AUG-20 |
RCPD-20-004 |
Opportunity to Comment on Draft Final NUREG-1757, Volume 2, Consolidated Decommissioning Guidance, Characterization, Survey, and Determination of Radiological Criteria (RCPD-20-004). RCPD-20-004 provides States an opportunity to comment by 8/25/2020 on the draft final revision 2 of NUREG-1757, Volume 2, Consolidated Decommissioning Guidance, Characterization, Survey, and Determination of Radiological Criteria guidance document. This NUREG provides guidance on radiological surveys and dose modeling associated with decontamination and decommissioning of nuclear facilities with the ultimate goal of license termination. |
| 14-AUG-20 |
RCPD-20-006 |
Opportunity to Comment on the U.S. Nuclear Regulatory Commission's Draft Technical Evaluation Report for Exubrion Therapeutics' Proposed License Application Template for the Release of Dogs Following Treatment with a Tin-117M Colloid (RCPD-20-006). RCPD-20-006 offers States the opportunity to comment on NRC's draft report for Exubrion Therapeutics's license application for the use of a Tin-117M colloid to treat dogs for arthritis; comments are due 8/14/2020. |
| 13-AUG-20 |
STC-20-051
|
Opportunity to Comment on Draft Revision to Management Directive and Handbook 5.8, "Proposed Section 274b. Agreements With States" (STC-20-051). STC-20-051 offers Agreement States the opportunity to comment on the proposed revisions to the Management Directive (MD) and Handbook 5.8, "Proposed Section 274B. Agreements with States." by 08/13/2020. |
